CoChat

Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors

Open access
Erikstrup, Christian, Hother, Christoffer Egeberg, Pedersen, Ole Birger Vestager, Mølbak, Kåre, Skov, Robert Leo, Holm, Dorte Kinggaard, Sækmose, Susanne Gjørup, Nilsson, Anna Christine, Brooks, Patrick Terrence, Boldsen, Jens Kjærgaard, Mikkelsen, Christina, Gybel-Brask, Mikkel, Sørensen, Erik, Dinh, Khoa Manh, Mikkelsen, Susan, Møller, Bjarne Kuno, Haunstrup, Thure, Harritshøj, Lene, Jensen, Bitten Aagaard, Hjalgrim, Henrik, Lillevang, Søren Thue, Ullum, Henrik · 2021 · Clinical Infectious Diseases

Published version of a preprint

Cited by 148

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: The pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has tremendous consequences for our societies. Knowledge of the seroprevalence of SARS-CoV-2 is needed to accurately monitor the spread of the epidemic and to calculate the infection fatality rate (IFR). These measures may help the authorities make informed decisions and adjust the current societal interventions. The objective was to perform nationwide real-time seroprevalence surveying among blood donors as a tool to estimate previous SARS-CoV-2 infections and the population-based IFR. Methods: Danish blood donors aged 17–69 years giving blood 6 April to 3 May were tested for SARS-CoV-2 immunoglobulin M and G antibodies using a commercial lateral flow test. Antibody status was compared between geographical areas, and an estimate of the IFR was calculated. Seroprevalence was adjusted for assay sensitivity and specificity taking the uncertainties of the test validation into account when reporting the 95% confidence intervals (CIs). Results: The first 20 640 blood donors were tested, and a combined adjusted seroprevalence of 1.9% (95% CI, .8–2.3) was calculated. The seroprevalence differed across areas. Using available data on fatalities and population numbers, a combined IFR in patients <70 years is estimated at 89 per 100 000 (95% CI, 72–211) infections. Conclusions: The IFR was estimated to be slightly lower than previously reported from other countries not using seroprevalence data. The IFR is likely severalfold lower than the current estimate. We have initiated real-time nationwide anti–SARS-CoV-2 seroprevalence surveying of blood donations as a tool in monitoring the epidemic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa849

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 6

  1. Ruan, 2020, Likelihood of survival of coronavirus disease 2019, 10.1016/S1473-3099(20)30257-7 · DOI · Paper page
  2. Ullum, 2015, Blood donation and blood donor mortality after adjustment for a healthy donor effect, Transfusion, 55, 2479, 10.1111/trf.13205 · DOI
  3. Sethuraman, 2020, Interpreting diagnostic tests for SARS-CoV-2, JAMA, 323, 2249, 10.1001/jama.2020.8259 · DOI · Paper page
  4. Verity, 2020, Estimates of the severity of coronavirus disease 2019: a model-based analysis, Lancet Infect Dis, 10.1016/S1473-3099(20)30243-7 · DOI · Paper page
  5. Burgdorf, 2017, Socio-demographic characteristics of Danish blood donors, PLoS One, 12, e0169112, 10.1371/journal.pone.0169112 · DOI
  6. CDC COVID-19 Response Team., 2020, Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12-March 16, 2020, MMWR Morb Mortal Wkly Rep, 69, 343, 10.15585/mmwr.mm6912e2 · DOI · Paper page

Cited by

See all 148

Metadata

Authors
Erikstrup, C., Hother, C. E., Pedersen, O. B. V., Mølbak, K., Skov, R. L., Holm, D. K., Sækmose, S. G., Nilsson, A. C., Brooks, P. T., Boldsen, J. K., Mikkelsen, C., Gybel-Brask, M., Sørensen, E., Dinh, K. M., Mikkelsen, S., Møller, B. K., Haunstrup, T., Harritshøj, L., Jensen, B. A., Hjalgrim, H., Lillevang, S. T., & Ullum, H.
Venue
Clinical Infectious Diseases
Published
2020-06-25
Volume
72
Issue
2
Pages
249-253
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3037177566
Cited by
148
References
4
FWCI
4.44
Type
journal article
Language
en
Open access
hybrid
Funders
Bestseller Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors. https://app.cochat.ai/papers/10.1093/cid/ciaa849
The paper
Erikstrup, C., Hother, C. E., Pedersen, O. B. V., Mølbak, K., Skov, R. L., Holm, D. K., Sækmose, S. G., Nilsson, A. C., Brooks, P. T., Boldsen, J. K., Mikkelsen, C., Gybel-Brask, M., Sørensen, E., Dinh, K. M., Mikkelsen, S., Møller, B. K., Haunstrup, T., Harritshøj, L., Jensen, B. A., . . . Ullum, H. (2021). Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa849

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.